InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by KREHER NERISSA, Directrice Médicale. Director active across 1 companies, notably Entrada Therapeutics, Inc.. Cumulatively, 3 disclosures have been recorded. The latest transaction was disclosed on 1 March 2022 — Attribution. Regulator: SEC (Form 4). The full history is openly available.
Declarations3 total
010,344 shares0
Common Stock
SEC:0001104659-22-030005:0·
€9,6515,200 shares@ €1.8560.0039% mcap100.0% of flow
Common Stock
SEC:0001104659-21-154295·
€9,6515,200 shares@ €1.8560.0039% mcap50.0% of flow
Common Stock
SEC:0001104659-21-154295:0·
3 of 3 declarations
About KREHER NERISSA
Nerissa Kreher is the Chief Medical Officer at Entrada Therapeutics, Inc. She oversees the clinical and medical operations of the company, ensuring that the treatments developed are safe and effective.
